Published in Medicine and Law Weekly, February 13th, 2009
In a related move, Paul Sylvestre, President of I.T.I. Bio-Tech www.itilaval.com has been appointed CEO of MonArc Corporation.
ITI is a Bio-Tech company, specializing in the manufacturing of products Eliminating Airborne Volatile Organic Compounds (VOC'S). Considered a factor in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.